Levels of Genotoxic and Carcinogenic Ingredients in Plant Food Supplements and Associated Risk Assessment

Suzanne J. P. L. van den Berg, Patrizia Restani, Marelle G. Boersma, Luc Delmulle, Ivonne M. C. M. Rietjens

.

DOI: 10.4236/fns.2011.29134                

Abstract

The present study describes the selection, analysis and risk assessment of genotoxic and carcinogenic ingredients of botanicals and botanical preparations which can be found in food and plant food supplements (PFS). First an inventory was made of botanical ingredients that are of possible concern for human health because of their genotoxic and/or carcinogenic properties. In total, 30 botanical ingredients were selected and subsequently judged for their actual genotoxic and/or carcinogenic potential. Among the 30 compounds considered, 18 compounds were judged to be both genotoxic and carcinogenic. Interestingly, the majority of these compounds belong to the group of alkenylbenzenes or unsaturated pyrrolizidine alkaloids. Subsequently, based on available carcinogenicity data and estimated daily human exposure that was determined focusing on the intake from PFS, the Margin of Exposure (MOE) was calculated for the alkenylbenzenes estragole, methyleugenol, safrole and β-asarone. Calculating the MOEs for intake estimates of these alkenylbenzenes from PFS resulted in MOE values that were generally lower than 10,000 and often lower than 100. In some cases the MOE was even below 10 meaning that the estimated daily intake is in the range of dose levels causing malignant tumors in experimental animals. This result indicates that the use of PFS containing the genotoxic carcinogens estragole, methyleugenol, safrole or β-asarone might raise a potential concern for human health and would be of high priority for risk management.

Keywords

Plant Food Supplements, Genotoxicity, Carcinogenicity, Dietary Exposure, Benchmark Dose Modeling, Margin of Exposure, Alkenylbenzenes, Chemical Analysis, Risk Assessment

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	I. M. C. M. Rietjens, W. Slob, C. Galli and V. Silano, “Risk Assessment of Botanicals and Botanical Preparations Intended for Use in Food and Food Supplements: Emerging Issues,” Toxicology Letters, Vol. 180, No. 2, 2008, pp. 131-136. doi:10.1016/j.toxlet.2008.05.024
[2]	Scientific Committee on Food (SCF), “Opinion of the Scientific Committee on Food on Estragole (1-allyl-4-methoxybenzene),” European Commission Health and Consumer Protection Directorate-General, Brussel, 26 September 2001, pp. 1-10. http://ec.europa.eu/food/fs/sc/scf/out104_en.pdf
[3]	Scientific Committee on Food (SCF), “Opinion of the Scientific Committee on Food on Methyleugenol (1-allyl-1,2-dimethoxybenzene),” European Commission Health & Consumer Protection Directorate-General, Brussel, 26 September 2001, pp. 1-10. http://ec.europa.eu/food/fs/sc/scf/out102_en.pdf
[4]	Scientific Committee on Food (SCF), “Opinion of the Scientific Committee on Food on the safety of the presence of safrole (1-allyl-3,4-methylene dioxybenzene) in Flavourings and Other Food Ingredients with Flavouring Properties,” European Commission Health & Consumer Protection Directorate-General, Brussel, 9 January 2002, pp. 1-10. http://ec.europa.eu/food/fs/sc/scf/out116_en.pdf
[5]	Scientific Committee of the European Food Safety Authority, “Discussion Paper on Botanicals and Botanical Preparations Widely Used as Food Supplements and Related Products: Coherent and Comprehensive Risk Assessment and Consumer Information Approaches,” Brussels, 25 June 2004, pp. 1-6. http://www.efsa.europa.eu/fr/efsajournal/doc/1249.pdf
[6]	European Food Safety Authority, “Opinion of the Scientific Committee on a Request from EFSA Related to a Harmonised Approach for Risk Assessment of Substances Which Are Both Genotoxic and Carcinogenic,” The EFSA Journal, No. 282, 2005, pp. 1-31. http://www.efsa.europa.eu/en/efsajournal/doc/282.pdf
[7]	S. Barlow and J. Schlatter, “Risk Assessment of Carcinogens in Food,” Toxicology and Applied Pharmacology, Vol. 243, No. 2, 2010, pp. 180-190. doi:10.1016/j.taap.2009.11.004
[8]	S. J. P. L. Van den Berg, L. Serra-Majem, P. Coppens, I. M. C. M. Rietjens, “Safety Assessment of Plant Food Supplements (PFS),” Food and Function, 2011, In Press. http://pubs.rsc.org/en/content/articlepdf/2011/fo/c1fo10067j
[9]	Joint FAO/WHO Expert Committee on Food Additives, “Summary and conclusions,” Sixty-Fourth Meeting, Rome, 8-17 February 2005, pp. 1-18.
[10]	S. Barlow, A. G. Renwick, J. Kleiner, J. W. Bridges, L. Busk, E. Dybing, L. Edler, G. Eisenbrand, J. Fink Gremmels, A. Knaap, R. Kroes, D. Liem, D. J. Muller, S. Page, V. Rolland, J. Schlatter, A. Tritscher, W. Tueting and G. Wurtzen, “Risk Assessment of Substances that Are Both Genotoxic and Carcinogenic Report of an International Conference Organized by EFSA and WHO with Support of ILSI Europe,” Food and Chemical Toxicology, Vol. 44, No. 10, 2006, pp. 1636-1650. doi:10.1016/j.fct.2006.06.020
[11]	J. O'Brien, A. G. Renwick, A. Constable, E. Dybing, D. J. Muller, J. Schlatter, W. Slob, W. Tueting, J. van Benthem, G. M. Williams and A. Wolfreys, “Approaches to the Risk Assessment of Genotoxic Carcinogens in Food: A Critical Appraisal,” Food and Chemical Toxicology, Vol. 44, No. 10, 2006, pp. 1613-1635. doi:10.1016/j.fct.2006.07.004
[12]	US EPA (Environmental Protection Agency), “The Use of the Benchmark Dose Approach in Health Risk Assessment, EPA/630/R-94/007,” Office of Research and Development, US Environmental Protection Agency, Washington DC, 1995. http://www.epa.gov/raf/publications/pdfs/BENCHMARK.PDF
[13]	European Food Safety Authority; “Compendium of Botanicals That Have Been Reported to Contain Toxic, Addictive, Psychotropic or Other Substances of Concern on Request of EFSA,” EFSA Journal, Vol. 9, No. 7, 2009, pp. 1-100. http://www.efsa.europa.eu/it/scdocs/doc/280rax1.pdf
[14]	Codex Committee on Contaminants in Foods (CCCF), “Joint FAO/WHO Food standards programme,” Fourth Session, Izmir, 26-30 April 2010. http://www.foodtechnology.org/public-policy-and-regulations/advocacy/~/media/Public%20Policy/International%20Advocacy/CCCF%202010%20IFT%20CSE%20report.pdf.
[15]	Joint FAO/WHO Expert Committee on Food Additives, “Safety Evaluation of Certain Food Additives: WHO Food Additives Series, 60,” 2009. http://whqlibdoc.who.int/publications/2009/9789241660600_eng.pdf.
[16]	ECHA (European CHemicals Agency),”Guidance on Information Requirements and Chemical Safety Assessment. Characterisation of Dose [concentration]―Response for Human Health, European Chemicals Agency,” 2008. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_r8_en.pdf?vers=20_08_08
[17]	D. Benford, P. M. Bolger, P. Carthew, M. Coulet, M. DiNovi, J. C. Leblanc, A. G. Renwick, W. Setzer, J. Schlatter, B. Smith, W. Slob, G. Williams and T. Wildemann, “Application of the Margin of Exposure (MOE) Approach to Substances in Food That Are Genotoxic and Carcinogenic,” Food and Chemical Toxicology, Vol. 48, Suppl 1, 2010, pp. S2-24. doi:10.1016/j.fct.2009.11.003
[18]	L. S. Gold, C. B. Sawyer, R. Magaw, G. M. Backman, M. de Veciana, R. Levinson, N. K. Hooper, W. R. Havender, L. Bernstein, R. Peto, et al., “A Carcinogenic Potency Database of the Standardized Results of Animal Bio- assays,” Environmental Health Perspectives, Vol. 58, No. 12, 1984, pp. 9-319. doi:10.1289/ehp.84589
[19]	W. Slob, “Dose-Response Modeling of Continuous End Points,” Toxicological Sciences, Vol. 66, No. 2, 2002, pp. 298-312. doi:10.1093/toxsci/66.2.298
[20]	A. Gursale, V. Dighe and G. Parekh, “Simultaneous Quantitative Determination of Cinnamaldehyde and Methyl Eugenol from Stem Bark of Cinnamomum Zeylanicum Blume Using RP-HPLC,” Journal of Chromatographic Science, Vol. 48, No. 1, 2010, pp. 59-62.
[21]	P. Newberne, R. L. Smith, J. Doull, J. I. Goodman, I. C. Munro, P. S. Portoghese, B. M. Wagner, C. S. Weil, L. A. Woods, T. B. Adams, C. D. Lucas and R. A. Ford, “The FEMA GRAS Assessment of Trans-Anethole Used as a Flavouring Substance. Flavour and Extract Manufacturer’s Association,” Food and Chemical Toxicology, Vol. 37, No. 7, 1999, pp. 789-811. doi:10.1016/S0278-6915(99)00037-X
[22]	E. C. Miller, A. B. Swanson, D. H. Phillips, T. L. Fletcher, A. Liem and J. A. Miller, “Structure-Activity Studies of the Carcinogenicities in the Mouse and Rat of Some Naturally Occurring and Synthetic Alkenylbenzene Derivatives Related to Safrole and Estragole,” Cancer Research, Vol. 43, No. 3, 1983, pp. 1124-1134.
[23]	K. Randerath, E. Randerath, H. P. Agrawal, R. C. Gupta, M. E. Schurdak and M. V. Reddy, “Post-labeling Methods for Carcinogen-DNA Adduct Analysis,” Environmen- tal Health Perspectives, Vol. 62, No. 10, 1985, pp. 57-65. doi:10.1289/ehp.856257
[24]	G. D. Zhou, B. Moorthy, J. Bi, K. C. Donnelly and K. Randerath, “DNA Adducts from Alkoxyallylbenzene Herb and Spice Constituents in Cultured Human (HepG2) Cells,” Environmental and Molecular Mutagenesis, Vol. 48, No. 9, 2007, pp. 715-721. doi:10.1002/em.20348
[25]	D. H. Philips, M. V. Reddy and K. Randerath, “32P-Post- Labelling Analysis of DNA Adducts Formed in the Livers of Animals Treated with Safrole, Estragole and Other Naturally-Occurring Alkenylbenzenes. II. Newborn Male B6C3F1 Mice,” Carcinogenesis, Vol. 5, No. 12, 1984, pp. 1623-1628. doi:10.1093/carcin/5.12.1623
[26]	Scientific Committee on Food (SCF), “Opinion of the Scientific Committee on Food on the Presence of β- Asarone in Flavourings and Other Food Ingredients with Flavouring Properties,” European Commission Health & Consumer Protection Directorate-General, Brussel, 8 January 2002, pp. 1-15. http://ec.europa.eu/food/fs/sc/scf/out111_en.pdf
[27]	V. M. Arlt, M. Stiborova and H. H. Schmeiser, “Aristolochic Acid as a Probable Human Cancer Hazard in Herbal Remedies: A Review,” Mutagenesis, Vol. 17, No. 4, 2002, pp. 265-277. doi:10.1093/mutage/17.4.265
[28]	European Food Safety Authority (EFSA), “Flavouring Group Evaluation 61, Revision 1 (FGE.61Rev1)1: Consideration of Aliphatic Acetals Evaluated by JECFA (57th meeting) Structurally Related to Acetals of Branched- and Straight-Chain Aliphatic Saturated Primary Alcohols and Branched- and Straight-Chain Saturated Aldehydes and One Orthoester of Formic Acid Evaluated by EFSA in FGE.03Rev1 (2008),” The EFSA Journal, No. 1026, 2009, pp. 1-37. http://www.efsa.europa.eu/en/efsajournal/doc/1026.pdf
[29]	National Toxicology Program (NTP), “Toxicology and Carcinogenesis Studies of Citral (microencapsulated) (CAS No. 5392-40-5) in F344/N Rats and B6C3F1 Mice (feed studies),” National Toxicology Program Technical Report Series, No. 505, 2003, pp. 1-270.
[30]	Scientific Committee on Food (SCF), “Opinion on Coumarin,” European Commission Health & Consumer Protection Directorate-General, Brussel, 22 September 1999, pp. 1-11. http://ec.europa.eu/food/fs/sc/scf/out40_en.pdf
[31]	National Toxicology Program (NTP), “NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies),” National Toxicology Program Technical Re- port Series, No. 422, 1993, pp. 1-340.
[32]	Scientific Committee on Food (SCF), “Opinion on Coumarin (a constituent of natural flavouring source materials limited by annex II of flavourings directive 88/388/EEC),” 1994. http://ec.europa.eu/food/fs/sfp/addit_flavor/flavourings/coumarin_en.pdf
[33]	European Food Safety Authority (EFSA), “Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contacts with Food (AFC) on a Request from the Commission Related to Coumarin,” The EFSA Journal, No. 104, 2004, pp. 1-36. http://www.efsa.europa.eu/en/scdocs/doc/104.pdf
[34]	National Toxicology Program (NTP), “NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies),” National Toxicology Program Technical Report Series, No. 427, 1993, p. 1-275.
[35]	European Food Safety Authority (EFSA), “Scientific Opinion on the Re-Evaluation of Curcumin (E 100) as a Food Additive,” EFSA Journal, Vol. 8, 2010, pp. 1-46.
[36]	G. Hasheminejad and J. Caldwell, “Genotoxicity of the Alkenylbenzenes Alpha- and Beta-Asarone, Myristicin and Elimicin as Determined by the UDS Assay in Cultured Rat Hepatocytes,” Food and Chemical Toxicology, Vol. 32, No. 3, 1994, pp. 223-231. doi:10.1016/0278-6915(94)90194-5
[37]	R. W. Wiseman, E. C. Miller, J. A. Miller and A. Liem, “Structure-Activity Studies of the Hepatocarcinogenicities of Alkenylbenzene Derivatives Related to Estragole and Safrole on Administration to Preweanling Male C57BL/6J x C3H/HeJ F1 Mice,” Cancer Research, Vol. 47, No. 3, 1987, pp. 2275-2283.
[38]	National Toxicology Program (NTP), “Carcinogenesis Studies of Eugenol (CAS No. 97-53-0) in F344/N Rats and B6C3F1 Mice (Feed Studies),” National Toxicology Program Technical Report Series, No. 223, 1983, pp. 1-165.
[39]	European Food Safety Authority (EFSA), “Flavouring Group Evaluation 60 (FGE.60) 1: Consideration of Eugenol and Related Hydroxyallylbenzene Derivatives Eva- luated by JECFA (65th meeting) Structurally Related to Ring-Substituted Phenolic Substances Evaluated by EFSA in FGE.22 (2006) Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC),” The EFSA Journal, No. 965, 2009, pp. 1-53. http://www.efsa.europa.eu/en/efsajournal/doc/965.pdf
[40]	T. Chen, N. Mei and P. P. Fu, “Genotoxicity of Pyrrolizidine Alkaloids,” Journal of Applied Toxicology, Vol. 30, No. 3, 2010, pp. 183-196.
[41]	P. P. Fu, Q. Xia, G. Lin and M. W. Chou, “Pyrrolizidine Alkaloids-Genotoxicity, Metabolism Enzymes, Metabolic Activation, and Mechanisms,” Drug Metabolism Reviews, Vol. 36, No. 1, 2004, pp. 1-55. doi:10.1081/DMR-120028426
[42]	R. Schoental, “Pancreatic Islet-Cell and Other Tumors in Rats Given Heliotrine, a Monoester Pyrrolizidine Alkaloid, and Nicotinamide,” Cancer Research, Vol. 35, No. 8, 1975, pp. 2020-2024.
[43]	Scientific Committee on Food (SCF), “Opinion of the Scientific Committee on Food on Isosafrole,” European Commission Health & Consumer Protection Directorate-General, Brussel, 9 April 2003, pp. 1-10. http://ec.europa.eu/food/fs/sc/scf/out188_en.pdf
[44]	National Toxicology Program (NTP), “Bioassay of Lasiocarpine for Possible Carcinogenicity,” National Toxico- logy Program Technical Report Series, No. 39, 1978, pp. 1-66.
[45]	National Toxicology Program (NTP), “Toxicology and Carcinogenesis Studies of 8-Methoxypsoralen (CAS No. 298-81-7) in F344/N Rats (Gavage Studies),” National Toxicology Program Technical Report Series, No. 359, 1989, pp. 1-130.
[46]	H. Mori, S. Sugie, N. Yoshimi, Y. Asada, T. Furuya and G. M. Williams, “Genotoxicity of a Variety of Pyrrolizidine Alkaloids in the Hepatocyte Primary Culture-DNA Repair Test Using Rat, Mouse, and Hamster Hepatocytes,” Cancer Research, Vol. 45, No. 7, 1985, pp. 3125-3129.
[47]	P. M. Newberne. A. E. Rogers, “Nutrition, Monocrotaline, and Aflatoxin B1 in Liver Carcinogenesis,” Plant Foods for Man, Vol. 1, 1973, pp. 23-31
[48]	Committee on Carcinogenicity (COC), “Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment,” Annual Report, 2008. http://cot.food.gov.uk/pdfs/cocsection2008.pdf
[49]	National Toxicology Program (NTP), “Toxicology and Carcinogenesis Studies of β-Myrcene (CAS No. 123-35-3) in F344/N Rats and B6C3F1 Mice (Gavage studies)” National Toxicology Program Technical Report Series, No. 557, 2009, pp. 1-191.
[50]	European Food Safety Authority (EFSA), “Flavouring Group Evaluation 78 (FGE.78). Consideration of Aliphatic and Alicyclic and Aromatic Hydrocarbons Evaluated by JECFA (63rd meeting) Structurally Related to Aliphatic and Aromatic Hydrocarbons Evaluated by EFSA in FGE.25 Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC),” The EFSA Journal Vol. 931, 2009, pp. 1-59. http://www.efsa.europa.eu/en/efsajournal/doc/931.pdf
[51]	A. Matsuoka, A. Hirosawa, S. Natori, S. Iwasaki, T. Sofuni and M. Ishidate Jr., “Mutagenicity of Ptaquiloside, the Carcinogen in Bracken, and Its related Illudane-Type Sesquiterpenes. II. Chromosomal Aberration Tests with Cultured Mammalian Cells,” Mutation Research, Vol. 215, No. 2, 1989, pp. 179-185. doi:10.1016/0027-5107(89)90182-6
[52]	H. Mori, S. Sugie, I. Hirono, K. Yamada, H. Niwa and M. Ojika, “Genotoxicity of Ptaquiloside, a Bracken Carcinogen, in the Hepatocyte Primary Culture/DNA-Repair Test,” Mutation Research, Vol. 143, No. 1-2, 1985, pp. 75-78. doi:10.1016/0165-7992(85)90108-3
[53]	B. Schmidt, L. H. Rasmussen, G. W. Svendsen, F. Ingerslev and H. C. Hansen, “Genotoxic Activity and Inhibition of Soil Respiration by Ptaquiloside, a Bracken Fern Carcinogen,” Environmental Toxicology & Chemistry, Vol. 24, No. 11, 2005, pp. 2751-2756. doi:10.1897/04-469R.1
[54]	I. Hirono, S. Aiso, T. Yamaji, H. Mori, K. Yamada, H. Niwa, M. Ojika, K. Wakamatsu, H. Kigoshi, K. Niiyama, Y. Uosaki, “Carcinogenicity in Rats of Ptaquiloside Isolated from Bracken,” Gann, Vol. 75, No. 10, 1984, pp. 833- 836.
[55]	National Toxicology Program (NTP), “Draft Report on the Toxicology and Carcinogenesis Studies of Pulegone (CAS No. 89-82-7) in F344/N Rats and B6C3F1 Mice (Gavage studies),” National Toxicology Program Technical Report Series, No. 563, 2009, pp. 1-230.
[56]	National Toxicology Program (NTP), “Toxicology and Carcinogenesis Studies of Quercetin (CAS No. 117-39-5) in F344 Rats (Feed Studies),” National Toxicology Program Technical Report Series, No. 409, 1992, pp. 1-171.
[57]	M. Harwood, B. Danielewska-Nikiel, J. F. Borzelleca, G. W. Flamm, G. M. Williams and T. C. Lines, “A Critical Review of the Data Related to the Safety of Quercetin and Lack of Evidence of in vivo Toxicity, Including Lack of Genotoxic/Carcinogenic Properties,” Food and Chemical Toxicology, Vol. 45, No. 11, 2007, pp. 2179-2205. doi:10.1016/j.fct.2007.05.015
[58]	G. Brambilla and A. Martelli, “Genotoxicity and carcinogenicity studies of antihypertensive agents” Mutation Research, Vol. 612, No. 2, 2006, pp. 115-149. doi:10.1016/j.mrrev.2005.12.002
[59]	National Toxicology Program (NTP), “Bioassay of Reserpine for Possible Carcinogenicity (CAS No. 50-55-5),” National Toxicology Program Technical Report Series, No. 193, 1982, pp. 1-123.
[60]	National Toxicology Program (NTP), “Toxicology and Carcinogenesis Studies of Riddelliine (CAS No. 23246-96-0) in F344/N Rats and B6C3F1 Mice (gavage studies),” National Toxicology Program Technical Report Series, 2003, pp. 1-280.
[61]	C. E. Green, J. H. Segall and J. L. Byard, “Metabolism, Cytotoxicity, and Genotoxicity of the Pyrrolizidine Alkaloid Senecionine in Primary Cultures of Rat Hepatocytes,” Toxicology and Applied Pharmacology, Vol. 60, No. 2, 1981, pp. 176-185. doi:10.1016/0041-008X(91)90221-Y
[62]	International Agency for Research on Cancer (IARC), “Some Food Additives, Feed Additives and Naturally Occurring Substances. Summary of Data Reported and Evaluation-Senkirkine,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 31, 1983, pp. 231.
[63]	National Toxicology Program (NTP), “NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies),” National Toxicology Program Technical Report Series, No. 491, 2000, pp. 1-412.
[64]	JECFA, “Joint FAO/WHO Expert Committee on Food Additives. Monograph on β-Asarone. WHO Food Additive Series No. 16,” 1981. http://www.inchem.org/documents/jecfa/jecmono/v16je04.htm
[65]	V. D. Zheljazkov, A. Callahan and C. L. Cantrell, “Yield and Oil Composition of 38 Basil (Ocimum basilicum L.) Accessions Grown in Mississippi,” Journal of Agricultural and Food Chemistry, Vol. 56, No. 1, 2008, pp. 241-245. doi:10.1021/jf072447y
[66]	R. L. Smith, T. B. Adams, J. Doull, V. J. Feron, J. I. Goodman, L. J. Marnett, P. S. Portoghese, W. J. Waddell, B. M. Wagner, A. E. Rogers, J. Caldwell and I. G. Sipes, “Safety Assessment of Allylalkoxybenzene Derivatives used as Flavouring Substances―Methyl Eugenol and Estragole,” Food and Chemical Toxicology, Vol. 40, No. 7, 2002, pp. 851-870. doi:10.1016/S0278-6915(02)00012-1
[67]	A. Simi?, M. D. Sokovi?, M. Risti?, S. Gruji?-Jovanovi?, J. Vukojevi? and P. D. Marin, “The Chemical Composition of Some Lauraceae Essential Oils and Their Antifungal Activities,” Phytotherapy Research, Vol. 18, No. 9, 2004, pp. 713-717. doi:10.1002/ptr.1516
[68]	K. M. Maya, T. J. Zachariah and B. Krishnamoorthy, “Chemical Composition of Nutmeg (Myristica fragrans Houtt.) Accessions,” Journal of Spices and Aromatic Crops, Vol. 13, No. 2, 2004, pp. 135-139.
[69]	M. De Vincenzi, M. Silano, P. Stacchini and B. Scazzocchio, “Constituents of Aromatic Plants: I. Methyleuge- nol,” Fitoterapia, Vol. 71, No. 2, 2000, pp. 216-221. doi:10.1016/S0367-326X(99)00150-1
[70]	R. Wang, R. Wang and B. Yang, “Extraction of Essential Oils from Five Cinnamon Leaves and Identification of Their Volatile Compound Compositions,” Innovative Food Science and Emerging Technologies, Vol. 10, No. 2, 2009, pp. 289-292. doi:10.1016/j.ifset.2008.12.002
[71]	L. C. M. Rost and R. Bas, “Biosystematic Investigations with Acorus L-3 Communication. Constituents of Essential Oils,” Journal of medicinal plant research, Vol. 36, No. 8, 1979, pp. 350-361.
[72]	L. F. di Cesare, E. Forni, D. Viscardi and R. C. Nani, “Changes in the Chemical Composition of Basil Caused by Different Drying Procedures,” Journal of Agricultural and Food Chemistry, Vol. 51, No. 12, 2003, pp. 3575-3581.
[73]	M. Miele, R. Dondero, G. Ciarallo and M. Mazzei, “Methyleugenol in Ocimum basilicum L. Cv. Genovese Gigante,” Journal of Agricultural and Food Chemistry, Vol. 49, No. 1, 2001, pp. 517-521. doi:10.1021/jf000865w
[74]	I. M. C. M. Rietjens, A. Punt, B. Schilter, G. Scholz, T. Delatour and P. J. van Bladeren, “In Silico Methods for Physiologically Based Biokinetic Models Describing Bioactivation and Detoxification of Coumarin and Estragole: Implications for Risk Assessment,” Molecular Nutrition and Food Research, Vol. 54, No. 2, 2010, pp. 195-207. doi:10.1002/mnfr.200900211
[75]	A. A. Al-Subeihi, B. Spenkelink, N. Rachmawati, M. G. Boersma, A. Punt, J. Vervoort, P. J. van Bladeren and I. M. C. M. Rietjens, “Physiologically Based Biokinetic model of Bioactivation and Detoxification of the Alkenylbenzene Methyleugenol in Rat,” Toxicology in vitro, Vol. 25, No. 1, 2011, pp. 267-285. doi:10.1016/j.tiv.2010.08.019
[76]	A. Punt, A. P. Freidig, T. Delatour, G. Scholz, M. G. Boersma, B. Schilter, P. J. van Bladeren and I. M.C. M. Rietjens, “A Physiologically Based Biokinetic (PBBK) Model for Estragole Bioactivation and Detoxification in Rat,” Toxicology and Applied Pharmacology, Vol. 231, No. 2, 2008, pp. 248-259. doi:10.1016/j.taap.2008.04.011
[77]	E. Martati, M. G. Boersma, A. Spenkelink, D. B. Khadka, A. Punt, J. Vervoort, P. J. van Bladeren and I. M. C .M. Rietjens, “Physiologically Based Biokinetic (PBBK) Model for Safrole Bioactivation and Detoxification in Rats,” Chemical Research in Toxicology, Vol. 24, No. 6, 2011, pp. 818-834. doi:10.1021/tx200032m
[78]	J. P. de Paula, P. V. Farago, J. L. C. Ribas, G. M. S. SpinardiI, P. M. Doll, R. F. Artoni and S. F. Zawadzka, “In vivo Evaluation of the Mutagenic Potential of Estragole and Eugenol Chemotypes of Ocimum selloi Benth. Essential Oil,” Latin American Journal of Pharmacy, Vol. 26, No. 6, 2007, pp. 846-851.
[79]	S. M. Jeurissen, A. Punt, T. Delatour and I. M. C. M. Rietjens, “Basil Extract Inhibits the Sulfotransferase Mediated Formation of DNA Adducts of the Procarcinogen 1’-Hydroxyestragole by Rat and Human Liver S9 Homogenates and in HepG2 Human Hepatoma Cells,” Food and Chemical Toxicology, Vol. 46, No. 6, 2008, pp. 2296-2302. doi:10.1016/j.fct.2008.03.010
[80]	W. Alhusainy, A. Paini, A. Punt, J. Louisse, B. Spenkelink, J. Vervoort, T. Delatour, G. Scholz, B. Schilter, T. Adams, P. J. van Bladeren and I. M. C. M. Rietjens, “Identification of Nevadensin as an Important Herb-Based Constituent Inhibiting Estragolebioactivation and Physiology-Based Biokinetic Modeling of Its Possible in vivo Effect,” Toxicology and Applied Pharmacology, Vol. 245, No. 2, 2010, pp. 179-190.